Constraint Induced Movement Therapy for Walking in Individuals Post Stroke



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:21 - 75
Updated:9/16/2018
Start Date:August 14, 2017
End Date:July 30, 2020
Contact:Weena Dee, PT
Email:wdee@ric.org
Phone:312-238-7503

Use our guide to learn which trials are right for you!

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training
only on walking function in individuals post-stroke, a 6 week, single-blind, randomized
training study will be conducted with three assessments of gait to determine the training
effect. Subjects will be randomized to either the CIMT or treadmill training only groups at
the initial test. Following the initial test, individuals from the 2 groups will undergo
intensive locomotor training. Training will be performed 3 times per week for 6 weeks with
the training time for each visit set to 45 minutes as tolerated. Data collection will proceed
until 36 subjects from 2 groups have been trained.

To determine the effect of constraint induced movement therapy (CIMT) on locomotor function
in individuals post stroke. In order to compare the effect of CIMT vs. treadmill training
only on walking function in individuals post-stroke, a 6 week, single-blind, randomized
training study will be conducted with three assessments of gait to determine the training
effect. Subjects will be blocked by gait speed into slow (< 0.4 m/s) or fast (≥ 0.4 m/s)
subgroups and randomized to either the CIMT or treadmill training only groups at the initial
test. Following the initial test, individuals from the 2 groups will undergo intensive
locomotor training. Training will be performed 3 times per week for 6 weeks with the training
time for each visit set to 45 minutes as tolerated, excluding set up time. Data collection
will proceed until 36 subjects from 2 groups have been trained.

Inclusion Criteria:

1. age between 21 and 75 years;

2. history of unilateral, supratentorial, ischemic or hemorrhagic stroke;

3. no prior stroke;

4. demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);

5. able to stand and walk (>10 meters) without physical assistance.

Exclusion Criteria:

1. significant cardiorespiratory/metabolic disease;

2. other neurological or orthopedic injury that impairs locomotion;

3. scores on the Mini Mental Status examination < 24;

4. stroke of the brainstem or cerebellar lesions;

5. uncontrolled hypertension (systolic > 200 mm Hg, diastolic > 110 mm Hg);

6. botox injection within 6 months of starting the study.
We found this trial at
1
site
Chicago, Illinois 60611
Phone: 312-238-7503
?
mi
from
Chicago, IL
Click here to add this to my saved trials